OBJECTIVE: We studied the concordance of transgene expression in the transplanted heart using bicistronic adenoviral vector coding for a transgene of interest (human carcinoembryonic antigen: hCEA - beta human chorionic gonadotropin: betahCG) and for a marker imaging transgene (human sodium iodide symporter: hNIS). METHODS: Inbred Lewis rats were used for syngeneic heterotopic cardiac transplantation. Donor rat hearts were perfused ex vivo for 30 min prior to transplantation with University of Wisconsin (UW) solution (n=3), with 10(9) pfu/ml of adenovirus expressing hNIS (Ad-NIS; n=6), hNIS-hCEA (Ad-NIS-CEA; n=6) and hNIS-betahCG (Ad-NIS-CG; n=6). On postoperative day (POD) 5, 10, 15 all animals underwent micro-single photon emission computed tomography/computed tomography (SPECT/CT) imaging of the donor hearts after tail vein injection of 1000 microCi (123)I and blood sample collection for hCEA and betahCG quantification. RESULTS: Significantly higher image intensity was noted in the hearts perfused with Ad-NIS (1.1+/-0.2; 0.9+/-0.07), Ad-NIS-CEA (1.2+/-0.3; 0.9+/-0.1) and Ad-NIS-CG (1.1+/-0.1; 0.9+/-0.1) compared to UW group (0.44+/-0.03; 0.47+/-0.06) on POD 5 and 10 (p<0.05). Serum levels of hCEA and betahCG increased in animals showing high cardiac (123)I uptake, but not in those with lower uptake. Above this threshold, image intensities correlated well with serum levels of hCEA and betahCG (R(2)=0.99 and R(2)=0.96, respectively). CONCLUSIONS: These data demonstrate that hNIS is an excellent reporter gene for the transplanted heart. The expression level of hNIS can be accurately and non-invasively monitored by serial radioisotopic SPECT imaging. High concordance has been demonstrated between imaging and soluble marker peptides at the maximum transgene expression on POD 5.
OBJECTIVE: We studied the concordance of transgene expression in the transplanted heart using bicistronic adenoviral vector coding for a transgene of interest (human carcinoembryonic antigen: hCEA - beta human chorionic gonadotropin: betahCG) and for a marker imaging transgene (humansodium iodide symporter: hNIS). METHODS: Inbred Lewis rats were used for syngeneic heterotopic cardiac transplantation. Donorrat hearts were perfused ex vivo for 30 min prior to transplantation with University of Wisconsin (UW) solution (n=3), with 10(9) pfu/ml of adenovirus expressing hNIS (Ad-NIS; n=6), hNIS-hCEA (Ad-NIS-CEA; n=6) and hNIS-betahCG (Ad-NIS-CG; n=6). On postoperative day (POD) 5, 10, 15 all animals underwent micro-single photon emission computed tomography/computed tomography (SPECT/CT) imaging of the donor hearts after tail vein injection of 1000 microCi (123)I and blood sample collection for hCEA and betahCG quantification. RESULTS: Significantly higher image intensity was noted in the hearts perfused with Ad-NIS (1.1+/-0.2; 0.9+/-0.07), Ad-NIS-CEA (1.2+/-0.3; 0.9+/-0.1) and Ad-NIS-CG (1.1+/-0.1; 0.9+/-0.1) compared to UW group (0.44+/-0.03; 0.47+/-0.06) on POD 5 and 10 (p<0.05). Serum levels of hCEA and betahCG increased in animals showing high cardiac (123)I uptake, but not in those with lower uptake. Above this threshold, image intensities correlated well with serum levels of hCEA and betahCG (R(2)=0.99 and R(2)=0.96, respectively). CONCLUSIONS: These data demonstrate that hNIS is an excellent reporter gene for the transplanted heart. The expression level of hNIS can be accurately and non-invasively monitored by serial radioisotopic SPECT imaging. High concordance has been demonstrated between imaging and soluble marker peptides at the maximum transgene expression on POD 5.
Authors: Keiji Oi; William R Davies; Henry D Tazelaar; Kent R Bailey; Mark J Federspiel; Stephen J Russell; Christopher G A McGregor Journal: J Gene Med Date: 2006-07 Impact factor: 4.565
Authors: Johannes M Schirmer; Naoto Miyagi; Vinay P Rao; Davide Ricci; Mark J Federspiel; Robert M Kotin; Stephen J Russell; Christopher G A McGregor Journal: Transpl Int Date: 2007-04-02 Impact factor: 3.782
Authors: M Laitinen; J Hartikainen; M O Hiltunen; J Eränen; M Kiviniemi; O Närvänen; K Mäkinen; H Manninen; M Syvänne; J F Martin; M Laakso; S Ylä-Herttuala Journal: Hum Gene Ther Date: 2000-01-20 Impact factor: 5.695
Authors: T K Rosengart; L Y Lee; S R Patel; T A Sanborn; M Parikh; G W Bergman; R Hachamovitch; M Szulc; P D Kligfield; P M Okin; R T Hahn; R B Devereux; M R Post; N R Hackett; T Foster; T M Grasso; M L Lesser; O W Isom; R G Crystal Journal: Circulation Date: 1999-08-03 Impact factor: 29.690
Authors: Jianping Li; Eleonora Simeoni; Sylvain Fleury; Jean Dudler; Emma Fiorini; Lukas Kappenberger; Ludwig K von Segesser; Giuseppe Vassalli Journal: Eur J Cardiothorac Surg Date: 2006-03-07 Impact factor: 4.191
Authors: Stephanie K Carlson; Kelly L Classic; Elizabeth M Hadac; Claire E Bender; Bradley J Kemp; Val J Lowe; Tanya L Hoskin; Stephen J Russell Journal: Mol Imaging Biol Date: 2006 Nov-Dec Impact factor: 3.484
Authors: D Ricci; A A Mennander; N Miyagi; V P Rao; H D Tazelaar; K Classic; G W Byrne; S J Russell; C G A McGregor Journal: Transplant Proc Date: 2010-06 Impact factor: 1.066
Authors: S Diocou; A Volpe; M Jauregui-Osoro; M Boudjemeline; K Chuamsaamarkkee; F Man; P J Blower; T Ng; G E D Mullen; G O Fruhwirth Journal: Sci Rep Date: 2017-04-19 Impact factor: 4.379